Dr Katims on Characterizing Immune Phenotype in FGFR3-mutated Upper Tract Urothelial Carcinoma
Andrew Katims, MD, MPH, discusses research characterizing immune responses in the tumor microenvironment of FGFR3-mutated upper tract urothelial carcinoma using single-cell RNA-sequencing
Andrew Katims Memorial Sloan Kettering Cancer Center 2023 Aua Annual Meeting Immune Phenotype Fgfr Mutated Upper Tract Urothelial Carcinoma
Source: onclive.com